Clinical Study | Office of Clinical Research

Ecog Multiple Myeloma Equate Trial (Eaa181)

Posted Date: Apr 20, 2021

Investigator: Bryan Hambley
Type of Study: Drug

A randomized, phase 3 trial for newly diagnosed multiple myeloma comparing induction regimens in patients not planned for early autologous transplant.

Criteria:

Newly Diagnosed Adults With Multiple Myeloma.

Keywords:

Myeloma, Daratumumab, Mrd

For More Information:

Bryan Hambley
5138544268
hamblebc@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List